Other prior data have demonstrated that MLH1 and MSH2 carriers, especially males, are at higher risk for gastric cancer than female Lynch syndrome carriers and those with germline mutations in other Lynch syndrome genes [5,6,8]. The gene discussed is MSH2; the disease is Lynch syndrome.